These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 11592346

  • 1. Effect of probenecid on ventricular cerebrospinal fluid methotrexate pharmacokinetics after intralumbar administration in nonhuman primates.
    Salzer W, Widemann B, McCully C, Adamson PC, Balis FM.
    Cancer Chemother Pharmacol; 2001 Sep; 48(3):235-40. PubMed ID: 11592346
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of body position on ventricular CSF methotrexate concentration following intralumbar administration.
    Blaney SM, Poplack DG, Godwin K, McCully CL, Murphy R, Balis FM.
    J Clin Oncol; 1995 Jan; 13(1):177-9. PubMed ID: 7799017
    [Abstract] [Full Text] [Related]

  • 5. Comparison of pharmacokinetics and toxicity after high-dose methotrexate treatments in children with acute lymphoblastic leukemia.
    Csordas K, Hegyi M, Eipel OT, Muller J, Erdelyi DJ, Kovacs GT.
    Anticancer Drugs; 2013 Feb; 24(2):189-97. PubMed ID: 23187460
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Active transport of methotrexate from cerebrospinal fluid in humans.
    Bode U, Magrath IT, Bleyer WA, Poplack DG, Glaubiger DL.
    Cancer Res; 1980 Jul; 40(7):2184-7. PubMed ID: 7388786
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Chemotherapy administration directly into the fourth ventricle in a nonhuman primate model.
    Sandberg DI, Peet MM, Johnson MD, Cole P, Koru-Sengul T, Luqman AW.
    J Neurosurg Pediatr; 2012 May; 9(5):530-41. PubMed ID: 22546032
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of O6-benzylguanine and its active metabolite 8-oxo-O6-benzylguanine in plasma and cerebrospinal fluid after intrathecal administration of O6-benzylguanine in the nonhuman primate.
    Berg SL, Murry DJ, McCully CL, Godwin K, Balis FM.
    Clin Cancer Res; 1998 Nov; 4(11):2891-4. PubMed ID: 9829757
    [Abstract] [Full Text] [Related]

  • 14. Cerebral subarachnoid sampling of cerebrospinal fluid in the rhesus monkey.
    Bacher JD, Balis FM, McCully CL, Godwin KS.
    Lab Anim Sci; 1994 Apr; 44(2):148-52. PubMed ID: 8028278
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of methotrexate in plasma and cerebrospinal fluid.
    Morikawa N, Mori T, Abe T, Ghoda M, Takeyama M, Hori S.
    Ann Pharmacother; 1997 Oct; 31(10):1153-6. PubMed ID: 9337440
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Variability in methotrexate serum and cerebrospinal fluid pharmacokinetics in children with acute lymphocytic leukemia: relation to assay methodology and physiological variables.
    Seidel H, Andersen A, Kvaløy JT, Nygaard R, Moe PJ, Jacobsen G, Lindqvist B, Slørdal L.
    Leuk Res; 2000 Mar; 24(3):193-9. PubMed ID: 10739001
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.